Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-371
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
This appears to be a figure from a study showing the mean change from baseline in Total AUA Symptom Score (0 to 35) over different durations of treatment in weeks. The study compares the effectiveness of a treatment (2 different doses) and placebo. However, without more context or clearer text, it is difficult to determine specifics of the study or treatment.*
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
The text describes a figure labeled "Figure 2B" which shows the mean change from baseline in total AUA symptom score (ranging from 0 to 35) for different treatments. The treatments listed are "0.08mg LNt", "0.4mg", and "Placebo", with the corresponding score changes shown on the graph. The x-axis indicates the duration of treatment in weeks, while the y-axis shows the mean change values. There are also some numbers in parentheses next to each treatment indicating the sample size for each group at different time points.*
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
The text describes a figure labeled as 3A showing the mean increase in peak urine flow rate in L/sec for Study 1. The figure includes a graph with a line chart placed on the X-axis representing the duration of treatment in weeks and the Y-axis representing the mean change in mL/sec. The treatment options listed include 0.08mg, 2x 0.4mg, and placebo. However, the text does not provide a clear interpretation of the results or the purpose of the study.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
This is a graph showing the mean increase in peak urine flow rate (mL/Sec) for Study 2. The x-axis represents the duration of treatment in weeks while the y-axis shows the values of the urine flow rate. The graph shows different treatments denoted by letters and numbers. There is no further information available.*
63187-371-07 (Tamsulosin Fig6)
This is a description of a medication called Tamsulosin HCI 0.4mg, which comes in a bottle of 90 capsules from SNE MASTER. Each capsule contains tamsulosin hydrochloride USP NOC 63187.371.90 and is imprinted with a "D" on its cap and "53" on its body. The product ID is PT037190 and it was made by Aurobindo Pharma Limited in Hyderabad, India. The medication should be stored at 20°C-25°C and kept out of reach of children.*
Chemical Structure (Tamsulosin Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
